AtomVie Loader Image
Menux

Eckert & Ziegler and AtomVie Global Radiopharma Sign a Global Agreement for Lutetium-177 Supply

...

Details

BIO International Convention

...

Details

ASCO* Annual Meeting

...

Details

EANM*** Annual Congress

...

Details

SNMMI** Annual Meeting

...

Details

Canadian Radiotheranostics Leaders’ Summit

...

Details

Bloom Burton Healthcare Investor Conference

...

Details

AtomVie Global Radiopharma Appoints Dr. Pratibhash Chattopadhyay as Chief Business Officer to Accelerate Growth and Strengthen Leadership

...

Details

6th Annual Targeted Radiopharmaceuticals Summit – Europe 2024

...

Details

AtomVie Global Radiopharma and Radiopharm Theranostics Partner to Develop and Manufacture 177Lu-BetaBart Radioantibody for Treatment of Multiple Solid Tumors

...

Details

AtomVie Global Radiopharma Collaborates with RLS & UPPI to Strengthen its Existing U.S. Radiotherapeutic Distribution Network

...

Details

AtomVie Global Radiopharma (AtomVie) Is Featured On The Business Focus Magazine (Issue 113)

...

Details

AtomVie Global Radiopharma Raises Over $90M to Complete its New Facility Buildout

...

Details

Pinpointing the world’s next nucleus for radiopharmaceuticals

...

Details

AtomVie Global Radiopharma Inc. presents at key investor conferences

...

Details

McMaster, Terumo and AtomVie Global Radiopharma Inc. partner to manufacture medical devices for cancer treatment

...

Details

On this International Women’s Day, get to know AtomVie’s first COO, Dodi Adar!

To celebrate International Women’s Day, AtomVie Global Radiopharma Inc. (AtomVie) would like to highlight the women in our organization who...

Details

AtomVie Global Radiopharma Inc. builds industry-leading radiopharmaceutical CDMO facility in Hamilton, Ontario

...

Details

AtomVie Global Radiopharma Inc. joins the CNIC to bring new leadership, innovation, and collaboration to the radiopharmaceutical industry.

...

Details

New CPDC spinout company aims to become global leader in developing and distributing radiopharmaceuticals

...

Details